Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome

Cocorocchio, E; Nezi, L; Gandini, S; Manzo, T; Mazzarella, L; Lotti, F; Pala, L; Gnagnarella, P; Conforti, F; Pennacchioli, E; Fierro, Mt; Ribero, S; Senetta, R; Picciotto, F; Caliendo, V; Quaglino, P; Mazzarol, G; Orsolini, Gm; Prestianni, P; Ferrucci, Pf